18
Participants
Start Date
November 30, 2010
Primary Completion Date
May 31, 2013
Study Completion Date
June 30, 2013
Milnacipran
All subjects will be free of antidepressant medications or opiates, or any other medications used to treat pain for at least 2 weeks prior to initiation of dose titration. Patients will be allowed to escalate up to 100 mg a day: Day 1: 12.5 mg once a day; Days 2-3: 25 mg/day (12.5 mg twice daily); Days 4-7: 50 mg/day (25 mg twice daily); After Day 7: 100 mg/day (50 mg twice daily). The stable-dose phase will be a 10-week period during which patients will take medications at the final dose achieved (either 100 mg per day in divided doses, or the maximum tolerated dose of less than 100 mg per day).
UCLA Semel Institute, Los Angeles
Collaborators (1)
Forest Laboratories
INDUSTRY
University of California, Los Angeles
OTHER